DRP1/DMNL-1-mediated mitochondrial fission augments Rickettsia parkeri replication in macrophages

Insights

Pathogenic Rickettsia bacteria utilize host cell mitochondria for growth. Disrupting mitochondrial fission protein DRP1 significantly hinders Rickettsia parkeri replication in macrophages.

Area of Science:

  • Microbiology
  • Cell Biology
  • Pathogenesis

Background:

  • Pathogenic Spotted Fever Group (SFG) Rickettsia species infect host cells, including macrophages.
  • Mitochondrial dynamics are implicated in the pathogenesis of several intracellular bacterial pathogens.
  • Rickettsia parkeri's intracellular lifestyle and potential reliance on host cell metabolism are not fully understood.

Purpose of the Study:

  • To investigate the role of mitochondrial dynamics, specifically the protein DRP1 (dynamin-related protein 1), in the intracellular replication of Rickettsia parkeri within macrophages.
  • To determine if R. parkeri manipulates host cell mitochondria to promote its growth and survival.

Main Methods:

  • Infection of murine immortalized bone marrow derived macrophages (iBMDMs) and primary human monocyte derived macrophages with Rickettsia parkeri.
  • Assessment of mitochondrial content and dynamics (fission and network) using immunofluorescence microscopy.
  • Evaluation of R. parkeri growth in DRP1-deficient macrophages and measurement of host cell ATP production.

Main Results:

  • R. parkeri infection led to increased mitochondrial content and fission in macrophages.
  • Host cell ATP production increased during infection, primarily via mitochondrial respiration.
  • R. parkeri proliferation was significantly reduced in macrophages lacking DRP1.
  • Bacteria were frequently observed co-localized with mitochondrial fragments.

Conclusions:

  • Modulation of mitochondrial content and dynamics, particularly through DRP1-mediated fission, is crucial for R. parkeri replication and survival in macrophages.
  • Rickettsia species may have distinct metabolic requirements compared to other intracellular Gram-negative bacteria.
  • Targeting host mitochondrial pathways presents a potential avenue for therapeutic intervention against SFG Rickettsia infections.